Skip to main content

Eupraxia Pharmaceuticals Inc.

EPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001581178

No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Eupraxia Pharmaceuticals Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+19 vs. Q4 2025
Shares held
22.5M
+8.56M (+61.3%) vs. Q4 2025
Total value
$160.3M
+$55.1M (+52.5%) vs. Q4 2025
New holders
22
19 more added
Sold out
3
6 more reduced

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 55 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 8 institutionsQ3 2024: 8 institutionsQ4 2024: 9 institutionsQ1 2025: 11 institutionsQ2 2025: 14 institutionsQ3 2025: 27 institutionsQ4 2025: 36 institutionsQ1 2026: 55 institutionsQ2 2026: 67 institutions
Value heldQ1 2026: $160.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $4.43MQ3 2024: $4.55MQ4 2024: $5.63MQ1 2025: $7.09MQ2 2025: $10.9MQ3 2025: $75.3MQ4 2025: $105.1MQ1 2026: $160.3MQ2 2026: $163.6M
Institutions holding EPRX and their total value by quarter
QuarterHoldersValue
Q2 202667$163.6M
Q1 202655$160.3M
Q4 202536$105.1M
Q3 202527$75.3M
Q2 202514$10.9M
Q1 202511$7.09M
Q4 20249$5.63M
Q3 20248$4.55M
Q2 20248$4.43M
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Eupraxia Pharmaceuticals Inc.; share changes are against Q4 2025.

Institutions holding EPRX in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Beutel, Goodman & Co Ltd.3,666,465$26.4M0.18%−42,908−1.2%Reduced
Affinity Asset Advisors, LLC1,589,005$11.5M0.67%+1,289,005+429.7%Added
Balyasny Asset Management LLC1,350,000$9.77M0.02%00.0%Unchanged
Vivo Capital, LLC1,350,000$9.77M0.81%00.0%Unchanged
Ikarian Capital, LLC1,214,741$8.79M1.26%+604,741+99.1%Added
Great Point Partners LLC1,200,000$8.69M2.13%00.0%Unchanged
Scotia Capital Inc.1,342,178$7.24M0.03%+55,995+4.4%Added
Point72 Asset Management, L.P.967,575$7.01M0.01%+255,471+35.9%Added
UBS Group AG762,635$5.52M0.00%+542,611+246.6%Added
Seven Fleet Capital Management LP709,515$5.14M1.61%+709,515New
Redmile Group, LLC700,000$5.07M0.34%+700,000New
Rubric Capital Management LP691,170$5.00M0.06%+691,170New
Squadron Capital Management LLC680,000$4.92M1.97%+180,000+36.0%Added
Ally Bridge Group (NY) LLC660,375$4.78M4.75%+262,480+66.0%Added
Ameriprise Financial Inc649,074$4.70M0.00%+649,074New
PFM Health Sciences, LP540,871$3.92M0.41%+540,871New
Woodline Partners LP440,551$3.19M0.01%+440,551New
Alyeska Investment Group, L.P.375,000$2.71M0.01%+375,000New
Velan Capital Investment Management LP352,000$2.55M1.60%00.0%Unchanged
SummitTX Capital, L.P.327,997$2.37M0.08%+152,049+86.4%Added
Aisling Capital Management LP325,000$2.35M0.49%+325,000New
Boothbay Fund Management, LLC323,843$2.34M0.06%+167,512+107.2%Added
DV Trading LLC276,000$2.00M0.18%+276,000New
Bank of America Corp268,221$1.94M0.00%+14,900+5.9%Added
Royal Bank of Canada261,376$1.89M0.00%+65,099+33.2%Added
Citadel Advisors LLC230,176$1.67M0.00%+230,176New
Marshall Wace, LLP158,133$1.14M0.00%00.0%Unchanged
CIBC World Markets Inc.150,950$1.09M0.00%+92,900+160.0%Added
Delaney Capital Management Ltd.119,400$860.0K0.14%00.0%Unchanged
Acadian Asset Management LLC93,600$671.0K0.00%−62,166−39.9%Reduced
Hudson Bay Capital Management LP92,347$668.6K0.00%+92,347New
TD Waterhouse Canada Inc.81,725$589.8K0.00%+72,125+751.3%Added
Ingalls & Snyder LLC75,650$548.0K0.02%−1,750−2.3%Reduced
1832 Asset Management L.P.60,000$434.4K0.00%+27,862+86.7%Added
Goldman Sachs Group Inc53,080$384.3K0.00%−4,978−8.6%Reduced
Raymond James Financial Inc50,560$366.1K0.00%−2,412−4.6%Reduced
Diadema Partners LP40,000$289.6K0.12%+40,000New
Bank of Montreal38,250$276.1K0.00%+1,000+2.7%Added
Persistent Asset Partners Ltd37,926$274.6K0.11%+37,926New
Jane Street Group, LLC35,210$254.0K0.00%+5,588+18.9%Added
Toronto Dominion Bank32,898$237.5K0.00%+32,898New
Geode Capital Management, LLC25,613$185.4K0.00%+11,714+84.3%Added
Axq Capital, LP15,760$114.1K0.01%+15,760New
Integrated Wealth Concepts LLC12,000$86.9K0.00%+12,000New
TCI Wealth Advisors, Inc.11,000$79.6K0.00%00.0%Unchanged
Two Sigma Investments, LP10,800$78.2K0.00%+10,800New
Aptus Capital Advisors, LLC10,500$76.0K0.00%+500+5.0%Added
Guardian Wealth Advisors, LLC10,500$76.0K0.00%+500+5.0%Added
China Universal Asset Management Co., Ltd.10,000$72.4K0.01%+10,000New
Morgan Stanley8,820$63.9K0.00%+8,820New
Federation des caisses Desjardins du Quebec9,091$49.0K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA6,429$46.5K0.00%+6,429New
JPMorgan Chase & Co573$3.79K0.00%+573New
National Bank of Canada359$8120.00%−227−38.7%Reduced
Caitong International Asset Management Co., Ltd1$70.00%+1New
Arrowstreet Capital, Limited Partnership0$00.00%−278,064−100.0%Sold out
Quadrature Capital Ltd0$00.00%−43,186−100.0%Sold out
XTX Topco Ltd0$00.00%−16,180−100.0%Sold out